Zengqiang Lin - 01 Sep 2023 Form 3 Insider Report for Heyu Biological Technology Corp (HCIL)

Role
CEO, President, Director, 10%+ Owner
Signature
/s/ Zengqiang Lin
Issuer symbol
HCIL
Transactions as of
01 Sep 2023
Net transactions value
$0
Form type
3
Filing time
07 Sep 2023, 16:15:10 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HYBT Common stock, par value $0.001 353,322,843 01 Sep 2023 Sole director and shareholder of Zengqiang Investment Limited, which holds 353,322,843 shares.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.